Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCardiac Hypertrophy during Hypercholesterolemia and its Amelioration with Rosuvastatin and Amlodipine
Journal of Cardiovascular Pharmacology, 08/28/09
Kang BY et al. – This study provides evidence of cardiac hypertrophy in hypercholesterolemia independent of blood pressure change, LOX–1 and AT1R upregulation as possible signals for oxidant stress leading to alterations in cardiac structure during hypercholesterolemia, and most importantly, amelioration of cardiomyocyte hypertrophy and fibrosis by rosuvastatin and amlodipine.
Related Articles
Pre-lesional arterial endothelial phenotypes in hypercholesterolemia: Universal ABCA1 upregulation contrasts with region-specific gene expression in vivo
Heart And Circulatory Physiology, 11/19/09
Relevance Score: 88%
The Effect of Hypercholesterolemia on Rotator Cuff Disease
Clinical Orthopedics and Related Research, 11/13/09
Relevance Score: 83%
Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
Southern Medical Journal, 11/10/09
Relevance Score: 83%
Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in Sardinia
Atherosclerosis, 11/13/09
Relevance Score: 82%
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia
Pediatric Research, 11/09/09
Relevance Score: 82%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Sponsor
Article Search
Sponsor